Etude : QR-010
Type d'étude : Modulateur du CFTR
Titre : Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosiss
Phase : 1b
Promoteurs :
Age : 18 Years to 60 Years
Lien internet : https://clinicaltrials.gov/ct2/show/NCT02532764
Type d'étude : Modulateur du CFTR
Titre : Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosiss
Phase : 1b
Promoteurs :
Age : 18 Years to 60 Years
Lien internet : https://clinicaltrials.gov/ct2/show/NCT02532764